U.S. patent application number 15/401054 was filed with the patent office on 2021-01-28 for apparatus, system, and method for collecting a target material.
This patent application is currently assigned to RareCyte, Inc.. The applicant listed for this patent is RareCyte, Inc.. Invention is credited to Daniel Campton, Jonathan Lundt, Joshua Nordberg, Steve Quarre, Ronald Seubert, Lance U'Ren.
Application Number | 20210025794 15/401054 |
Document ID | / |
Family ID | 1000005326335 |
Filed Date | 2021-01-28 |
View All Diagrams
United States Patent
Application |
20210025794 |
Kind Code |
A9 |
Campton; Daniel ; et
al. |
January 28, 2021 |
APPARATUS, SYSTEM, AND METHOD FOR COLLECTING A TARGET MATERIAL
Abstract
This disclosure is directed to an apparatus, system and method
for retrieving a target material from a suspension. A system
includes a plurality of processing vessels and a collector. The
collector funnels portions of the target material from the
suspension through a cannula and into the processing vessels.
Sequential density fractionation is the division of a sample into
fractions or of a fraction of a sample into sub-fractions by a
step-wise or sequential process, such that each step or sequence
results in the collection or separation of a different fraction or
sub-fraction from the preceding and successive steps or sequences.
In other words, sequential density fractionation provides
individual sub-populations of a population or individual
sub-sub-populations of a sub-population of a population through a
series of steps.
Inventors: |
Campton; Daniel; (Seattle,
WA) ; Nordberg; Joshua; (Bainbridge Island, WA)
; Quarre; Steve; (Seattle, WA) ; Seubert;
Ronald; (Sammamish, WA) ; Lundt; Jonathan;
(Ann Arbor, MI) ; U'Ren; Lance; (Seattle,
WA) |
|
Applicant: |
Name |
City |
State |
Country |
Type |
RareCyte, Inc. |
Seattle |
WA |
US |
|
|
Assignee: |
RareCyte, Inc.
Seattle
WA
|
Prior
Publication: |
|
Document Identifier |
Publication Date |
|
US 20170191911 A1 |
July 6, 2017 |
|
|
Family ID: |
1000005326335 |
Appl. No.: |
15/401054 |
Filed: |
January 8, 2017 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
14610522 |
Jan 30, 2015 |
9539570 |
|
|
15401054 |
|
|
|
|
14495449 |
Sep 24, 2014 |
9039999 |
|
|
14610522 |
|
|
|
|
14266939 |
May 1, 2014 |
|
|
|
14495449 |
|
|
|
|
14090337 |
Nov 26, 2013 |
|
|
|
14495449 |
|
|
|
|
61935457 |
Feb 4, 2014 |
|
|
|
61818301 |
May 1, 2013 |
|
|
|
61869866 |
Aug 26, 2013 |
|
|
|
61935457 |
Feb 4, 2014 |
|
|
|
61732029 |
Nov 30, 2012 |
|
|
|
61745094 |
Dec 21, 2012 |
|
|
|
61791883 |
Mar 15, 2013 |
|
|
|
61818301 |
May 1, 2013 |
|
|
|
61869866 |
Aug 26, 2013 |
|
|
|
Current U.S.
Class: |
1/1 |
Current CPC
Class: |
B01L 3/50215 20130101;
B01L 2200/026 20130101; B01L 2300/087 20130101; B01L 2200/0631
20130101; G01N 33/491 20130101; B01L 2300/0848 20130101; B01D
21/262 20130101; G01N 1/40 20130101; B01L 3/502 20130101; B01L
2200/0647 20130101; B01L 2300/0672 20130101; B01L 2200/0689
20130101 |
International
Class: |
G01N 1/40 20060101
G01N001/40; G01N 33/49 20060101 G01N033/49; B01L 3/00 20060101
B01L003/00; B01D 21/26 20060101 B01D021/26 |
Claims
1. A system comprising: a primary vessel comprising an open end and
a suspension comprising a target material comprising at least a
first sub-fraction and a second sub-fraction; a first processing
vessel comprising a first end comprising a plug, an inner cavity,
and a first displacement fluid comprising a density greater than a
density of the first sub-fraction of the target material, wherein
the first displacement fluid is located within the inner cavity; a
second processing vessel comprising a first end comprising a plug,
an inner cavity, and a second displacement fluid comprising a
density greater than a density of the second sub-fraction of the
target material, wherein the second displacement fluid is located
within the inner cavity; and a device at least partially located
within the open end of the primary vessel, the device comprising a
cannula, wherein the cannula extends through the plug of the first
processing vessel and accesses the inner cavity of the first
processing vessel, thereby mating the first processing vessel and
the device and fluidly connecting the primary vessel to the first
processing vessel, wherein the device extends upwardly from the
open end of the primary vessel, wherein the processing vessel
extends upwardly from the device, wherein the first sub-fraction is
less dense than the second sub-fraction, and wherein the first
displacement fluid is less dense than the second sub-fraction and
the second displacement fluid.
2. The system of claim 1, wherein the plugs of the first and second
processing vessels are resealable.
3. The system of claim 2, further comprising a float located at a
longitudinal position within the primary vessel.
4. The system of claim 3, further comprising a sealing ring located
circumferentially around the primary vessel at the same
longitudinal position as at least a portion of the float within the
primary vessel.
5. The system of claim 3, further comprising a seal between an
inner wall of the primary vessel and a portion of the float.
6. The system of claim 1, further comprising a seal between an end
of the device and an inner wall of the primary vessel to maintain a
fluid-tight sealing engagement between the end of the device and
inner wall of the primary vessel.
7. The system of claim 1, wherein the first and second displacement
fluids are selected from the group consisting of: a solution of
colloidal silica particles coated with polyvinylpyrrolidone, a
polysaccharide solution, iodixanol, a liquid wax, an oil, a gas,
olive oil, mineral oil, silicone oil, immersion oil, mineral oil,
paraffin oil, silicon oil, fluorosilicone, perfluorodecalin,
perfluoroperhydrophenanthrene, perfluorooctylbromide, ionic
liquids, a polymer-based solution, a surfactant, a perfluoroketone,
perfluorocyclopentanone, perfluorocyclohexanone, a fluorinated
ketone, a hydrofluoroether, a hydrofluorocarbon, a perfluorocarbon,
a perfluoropolyether, silicon, a silicon-based liquid, phenylmethyl
siloxane, and combinations thereof.
7. The system of claim 1, wherein the collector further comprises:
a first end; a second end; a concave opening in the second end that
narrows to an apex; and a cavity with an opening at the first end,
wherein the cannula extends from the apex into the cavity, and
wherein the second end is at least partially located within the
open end of the primary vessel.
10. The system of claim 9, the first end comprising at least one
cut out at a top end.
11. The system of claim 1, further comprising: an n.sup.th
sub-fraction; and an n.sup.th processing vessel comprising a first
end comprising a plug, an inner cavity, and an n.sup.th
displacement fluid, wherein the n.sup.th displacement fluid is
located within the inner cavity wherein n.sup.th is equal to or
greater than 3.sup.rd, wherein each successive displacement fluid
has a density greater than each preceding displacement fluid,
wherein each successive sub-fraction has a density greater than
each preceding sub-fraction, and wherein n.sup.th displacement
fluid has a density greater than the n.sup.th sub-fraction.
12. The system of claim 1, wherein at least one of the
sub-fractions comprises fetal material.
13. The system of claim 1, wherein at least one of the
sub-fractions comprises a trophoblast, a nucleated red blood cell,
a fetal white blood cell, a circulating tumor cell, an immune cell,
or a spirochete.
14. The system of claim 1, wherein at least one of the
sub-fractions comprises at least one spirochete, malaria-inducing
agent, immune cell, or circulating tumor cell.
15. The system of claim 1, wherein the cannula is a tube, a needle,
or a non-coring needle.
16. The system of claim 1, wherein the cannula has a flat tip, a
beveled tip, a sharpened tip, or a tapered tip.
17. The system of claim 1, the processing vessel further comprising
a processing solution to effect a transformation on the target
material.
18. The system of claim 17, wherein the processing solution is a
preservative, a cell adhesion solution, or a dye.
Description
CROSS-REFERENCE TO A RELATED APPLICATION
[0001] This application is a continuation of application Ser. No.
14/610,522, filed Jan. 30, 2015, which claims the benefit of
Provisional Application No. 61/935,457, filed Feb. 4, 2014, and
which is also a continuation-in-part of application Ser. No.
14/495,449, filed Sep. 24, 2014, which is a continuation-in-part of
application Ser. No. 14/090,337, filed Nov. 26, 2013, which claims
the benefit of Provisional Application No. 61/732,029, filed Nov.
30, 2012; Provisional Application No. 61/1745,094, filed Dec. 21,
2012; Provisional Application No. 61/791,883, filed Mar. 15, 2013;
Provisional Application No. 61/818,301, filed May 1, 2013; and
Provisional Application No. 61/869,866, filed Aug. 26, 2013; and is
also a continuation-in-part of application Ser. No. 14/266,939,
filed May 1, 2014, which claims the benefit of Provisional
Application No. Provisional Application No. 61/818,301, filed May
1, 2013, Provisional Application No. 61/869,866, filed Aug. 26,
2013, and Provisional Application No. 61/935,457, filed Feb. 4,
2014.
TECHNICAL FIELD
[0002] This disclosure relates generally to density-based fluid
separation and, in particular, to retrieving a target material from
a suspension.
BACKGROUND
[0003] Suspensions often include materials of interests that are
difficult to detect, extract and isolate for analysis. For
instance, whole blood is a suspension of materials in a fluid. The
materials include billions of red and white blood cells and
platelets in a proteinaceous fluid called plasma. Whole blood is
routinely examined for the presence of abnormal organisms or cells,
such as ova, fetal cells, endothelial cells, parasites, bacteria,
and inflammatory cells, and viruses, including HIV,
cytomegalovirus, hepatitis C virus, and Epstein-Barr virus.
Currently, practitioners, researchers, and those working with blood
samples try to separate, isolate, and extract certain components of
a peripheral blood sample for examination. Typical techniques used
to analyze a blood sample include the steps of smearing a film of
blood on a slide and staining the film in a way that enables
certain components to be examined by bright field microscopy.
[0004] On the other hand, materials of interest that occur in a
suspension with very low concentrations are especially difficult if
not impossible to detect and analyze using many existing
techniques. Consider, for instance, circulating tumor cells
("CTCs"), which are cancer cells that have detached from a tumor,
circulate in the bloodstream, and may be regarded as seeds for
subsequent growth of additional tumors (i.e., metastasis) in
different tissues. The ability to accurately detect and analyze
CTCs is of particular interest to oncologists and cancer
researchers. However, CTCs occur in very low numbers in peripheral
whole blood samples. For instance, a 7.5 ml sample of peripheral
whole blood sample that contains as few as 5 CTCs is considered
clinically relevant for the diagnosis and treatment of a cancer
patient. In other words, detecting 5 CTCs in a 7.5 ml blood sample
is equivalent to detecting 1 CTC in a background of about 10
billion red and white blood cells, which is extremely time
consuming, costly and difficult to accomplish using blood film
analysis.
[0005] As a result, practitioners, researchers, and those working
with suspensions continue to seek systems and methods for accurate
analysis of suspensions for the presence or absence rare materials
of interest.
DESCRIPTION OF THE DRAWINGS
[0006] FIGS. 1A-1B show an example collector.
[0007] FIGS. 2A-2B show an example collector.
[0008] FIGS. 2C-2D show an example collector.
[0009] FIGS. 3A-3B show an example collector-processing vessel
system.
[0010] FIGS. 4A-4B show an example collector-canopy system.
[0011] FIGS. 5A-5B show an example sealing ring.
[0012] FIGS. 5C-5D show an example sealing ring.
[0013] FIGS. 5E-5F show an example sealing ring.
[0014] FIG. 5G shows an example sealing ring.
[0015] FIG. 6 shows a flow diagram of an example method for
retrieving a target material.
[0016] FIGS. 7A-7B show example float and primary vessel
systems.
[0017] FIG. 8 shows an example float and primary vessel system
having undergone density-based separation.
[0018] FIG. 9 shows an example sealing ring and the example float
and primary vessel system forming a seal.
[0019] FIGS. 10A-10G show an example system retrieving a target
material.
DETAILED DESCRIPTION
[0020] This disclosure is directed to an apparatus, system and
method for retrieving a target material from a suspension. A system
includes a plurality of processing vessels and a collector. The
collector funnels portions of the target material from the
suspension into the processing vessels. Sequential density
fractionation is the division of a sample into fractions or of a
fraction of a sample into sub-fractions by a step-wise or
sequential process, such that each step or sequence results in the
collection or separation of a different fraction or sub-fraction
from the preceding and successive steps or sequences. In other
words, sequential density fractionation provides individual
sub-populations of a population or individual sub-sub-populations
of a sub-population of a population through a series of steps.
Collector
[0021] FIG. 1A shows an isometric view of a collector 100. FIG. 1B
shows a cross-sectional view of the collector 100 taken along the
line I-I shown in FIG. 1A. Dot-dashed line 102 represents the
central or highest-symmetry axis of the collector 100. The
collector 100 may be sized and shaped to fit within a primary
vessel containing or capable of holding a suspension, the
suspension suspected of including a target material. The collector
100 funnels the target material from the suspension through a
cannula 106 and into a processing vessel (not shown) to be located
within a cavity 108. The collector 100 includes the main body 104
which includes a first end 110 and a second end 112. A seal may be
formed between the second end 112 and an inner wall of the primary
vessel to maintain a fluid-tight sealing engagement before, during,
and after centrifugation and to inhibit any portion of the
suspension from being located or flowing between an inner wall of
the primary vessel and a main body 104 of the collector 100. The
seal may be formed by an interference fit, a grease (such as vacuum
grease), an adhesive, an epoxy, by bonding (such as by thermal
bonding), by welding (such as by ultrasonic welding), by clamping
(such as with a ring or clamp), an insert (such as an O-ring or a
collar) that fits between the second end 112 and the inner wall of
the primary vessel, or the like. The main body 104 may be any
appropriate shape, including, but not limited to, cylindrical,
triangular, square, rectangular, or the like. The collector 100
also includes an internal funnel 114 which is a concave opening.
The funnel 114 may taper toward the cannula 106 from the second end
112. The funnel 114 channels a target material from below the
second end 112 into the cannula 106 which is connected to, and in
fluid communication with, an apex of the funnel 114. The apex of
the funnel 114 has a smaller diameter than the mouth of the funnel
114. The funnel 114 is formed by a tapered wall that may be
straight, curvilinear, arcuate, or the like. The funnel 114 may be
any appropriate shape, including, but not limited to, tubular,
spherical, domed, conical, rectangular, pyramidal, or the like.
Furthermore, the outermost diameter or edge of the funnel 114 may
be in continuous communication or constant contact (i.e. sit flush)
with the inner wall of the primary vessel such that no dead space
is present between the second end 112 of the collector 100 and the
inner wall of the primary vessel.
[0022] The cannula 106, such as a tube or a needle, including, but
not limited to a non-coring needle, extends from the apex of the
funnel 114 and into the cavity 108. In the example of FIG. 1, the
cavity 108 is a concave opening extending from the first end 110
into the main body 104 and may accept and support the processing
vessel (not shown). The cavity 108 may be any appropriate depth to
accept and support the processing vessel (not shown). The cannula
106 may extend any appropriate distance into the cavity 108 in
order to puncture the base of, or be inserted into, the processing
vessel (not shown). The cannula 106 may include a flat tip, a
beveled tip, a sharpened tip, or a tapered tip. Furthermore, the
cavity 108 may be any appropriate shape, including, but not limited
to, tubular, spherical, domed, conical, rectangular, pyramidal, or
the like. The cavity 108 may be threaded to engage a threaded
portion of the processing vessel (not shown).
[0023] The collector 100 may also include a retainer (not shown) to
prevent the collector 100 from sliding relative to the primary
vessel, thereby keeping the collector 100 at a pre-determined
height within the primary vessel. The retainer (not shown) may be a
shoulder extending radially from the first end 110, a clip, a
circular protrusion that extends beyond the circumference of the
cylindrical main body 104, a detent, or the like.
[0024] FIG. 2A shows an isometric view of a collector 200. FIG. 2B
shows a cross-section view of the collector 200 taken along the
line II-II shown in FIG. 2A. Dot-dashed line 202 represents the
central or highest-symmetry axis of the collector 200. The
collector 200 is similar to the collector 100, except that the
collector 200 includes a main body 204 that is more elongated than
the main body of the collector 100 in order to accommodate a
greater portion of the processing vessel (not shown). The main body
204 includes a first end 206 and a second end 208. A seal may be
formed between the second end 208 and an inner wall of the primary
vessel to maintain a fluid-tight sealing engagement before, during,
and after centrifugation and to inhibit any portion of the
suspension flowing between an inner wall of the primary vessel and
the main body 204 of the collector 200. The seal may be formed by
an interference fit, a grease (such as vacuum grease), an adhesive,
an epoxy, by bonding (such as thermal bonding), by welding (such as
ultrasonic welding), clamping (such as with a ring or clamp), an
insert (such as an O-ring or a collar) that fits between the second
end 208 and the inner wall of the primary vessel, or the like.
[0025] The first end 206 includes a cavity 212 dimensioned to
accept and hold at least a portion of the processing vessel (not
shown). The cavity 212 may have a tapered or stepped bottom end 220
on which the processing vessel (not shown) may rest. The first end
206 may also include at least one cut-out 210 to permit proper grip
of the processing vessel (not shown) for insertion and removal. The
collector 200 funnels the target material from the suspension into
an internal funnel 222 at the second end 208, through a cannula
214, and into a processing vessel (not shown) located within the
cavity 212. The cannula 214 may rest on a shelf 224 so that an
inner bore of the cannula 214 sits flush with an inner wall of the
funnel 222, as shown in FIG. 2B.
[0026] The collector 200 may include a shoulder 216, which extends
circumferentially around the main body 204. The shoulder 216 may be
larger than the inner diameter of the primary vessel so as to rest
on the open end of the primary vessel and, upon applying a lock
ring (not shown) to the outside of the primary vessel and the
shoulder 216, to inhibit movement of the collector 200 relative to
the primary vessel. The lock ring (not shown) applies pressure to
the primary vessel along the shoulder 216. The lock ring may be a
two-piece ring, a one piece ring wrapping around the full
circumference of the primary vessel, or a one piece ring wrapping
around less than the full circumference of the primary vessel, such
as one-half (1/2), five-eighths (5/8), two-thirds (2/3),
three-quarters (3/4), seven-eighths (7/8), or the like.
Alternatively, the shoulder 216 may fit within the primary vessel.
Alternatively, the shoulder 216 may be a clip, such that the
shoulder 216 may include a catch into which the primary vessel may
be inserted to inhibit movement of the collector 200 relative to
the primary vessel. Alternatively, the shoulder 216 may form an
interference fit with the inner wall of the primary vessel around
which a seal ring may be placed.
[0027] As shown in FIG. 2A, the collector 200 may include at least
one window 218 to access the cavity 212 through an inner wall of
the main body 204. The at least one window 218 permits an operator
to confirm proper placement of the processing vessel (not shown)
within the cavity 212. The at least one window 218 also allows
fluid discharged from the cannula 214 to flow out of the collector
200 and into a space formed between the collector 200 and the
primary vessel (not shown) and above the seal between the second
end 208 and the inner wall of the primary vessel.
[0028] FIG. 2C shows an isometric view of a collector 230. FIG. 2D
shows a cross-section view of the collector 230 taken along the
line shown in FIG. 2C. The collector 230 is similar to the
collector 200, except that the collector 230 includes a main body
238 including an extension 234 extending away from a first end 232
and a lid 236 to at least temporarily seal an opening 240 within
the extension 234. The opening 240 may be in fluid communication
with the cavity 212 at the first end 232. The lid 236 may
removable, puncturable and resealable (e.g. a flap lid), or
puncturable and non-resealable (e.g. a foil lid). The extension 234
may be sized to accept the lid 236 when punctured such that a
portion of the lid 236 does not extend into the cavity 212 at the
first end 232. Note that the collector 230 does not include the at
least one cut-out 210.
[0029] The main body can be composed of a variety of different
materials including, but not limited to, a ceramic; metals; organic
or inorganic materials; and plastic materials, such as
polyoxymethylene ("Delrin.RTM."), polystyrene, acrylonitrile
butadiene styrene ("ABS") copolymers, aromatic polycarbonates,
aromatic polyesters, carboxymethylcellulose, ethyl cellulose,
ethylene vinyl acetate copolymers, nylon, polyacetals,
polyacetates, polyacrylonitrile and other nitrile resins,
polyacrylonitrile-vinyl chloride copolymer, polyamides, aromatic
polyamides ("aramids"), polyamide-imide, polyarylates, polyarylene
oxides, polyarylene sulfides, polyarylsulfones, polybenzimidazole,
polybutylene terephthalate, polycarbonates, polyester, polyester
imides, polyether sulfones, polyetherimides, polyetherketones,
polyetheretherketones, polyethylene terephthalate, polyimides,
polymethacrylate, polyolefins (e.g., polyethylene, polypropylene),
polyallomers, polyoxadiazole, polyparaxylene, polyphenylene oxides
(PPO), modified PPOs, polystyrene, polysulfone, fluorine containing
polymer such as polytetrafluoroethylene, polyurethane, polyvinyl
acetate, polyvinyl alcohol, polyvinyl halides such as polyvinyl
chloride, polyvinyl chloride-vinyl acetate copolymer, polyvinyl
pyrrolidone, polyvinylidene chloride, specialty polymers,
polystyrene, polycarbonate, polypropylene, acrylonitrite
butadiene-styrene copolymer, butyl rubber, ethylene propylene diene
monomer; and combinations thereof.
[0030] The cannula can be composed of a variety of different
materials including, but not limited to, a ceramic; metals; organic
or inorganic materials; and plastic materials, such as a
polypropylene, acrylic, polycarbonate, or the like; and
combinations thereof. The cannula may have a tip along a
longitudinal axis of the cannula.
Collector-Processing Vessel System
[0031] FIG. 3A shows an exploded view of the example collector 200
and processing vessel 302. FIG. 3B shows a cross-sectional view of
the processing vessel 302 inserted into the cavity 212 at the first
end 206 of the collector 200 taken along the line IV-IV shown in
FIG. 3A. The collector 200 and processing vessel 302 form a
collector-processing vessel system 300. The processing vessel 302
may be an Eppendorf tube, a syringe, or a test tube and has a
closed end 304 and an open end 306. The open end 306 is sized to
receive a cap 308. The cap 308 may be composed of re-sealable
rubber or other suitable re-sealable material that can be
repeatedly punctured with a needle or other sharp implement to
access the contents stored in the processing vessel 302 interior
and re-seals when the needle or implement is removed.
Alternatively, the processing vessel 302 may also have two open
ends that are sized to receive caps. The processing vessel 302 may
have a tapered geometry that widens or narrows toward the open end
306; the processing vessel 302 may have a generally cylindrical
geometry; or, the processing vessel 302 may have a generally
cylindrical geometry in a first segment and a cone-shaped geometry
in a second segment, where the first and second segments are
connected and continuous with each other. Although at least one
segment of the processing vessel 302 has a circular cross-section,
in other embodiments, the at least one segment can have elliptical,
square, triangular, rectangular, octagonal, or any other suitable
cross-sectional shape. The processing vessel 302 can be composed of
a transparent, semitransparent, opaque, or translucent material,
such as plastic or another suitable material. The processing vessel
includes a central axis 314, which when inserted into the cavity
212 is coaxial with the central axis 202 of the collector 200. The
processing vessel 302 may also include a plug 310 at the closed end
304 to permit the introduction of the target material or to
exchange the target material with a displacement fluid 312. The
closed end 304 may be threaded to provide for a threaded connection
with a threaded cavity 212 of the collector 200. The processing
vessel 302 may be composed of glass, plastic, or other suitable
material.
[0032] The plug 310 may be composed of re-sealable rubber or other
suitable re-sealable material that can be repeatedly punctured with
a needle or other sharp implement to access the contents of the
processing vessel 302 interior or permit introduction of contents
into the processing vessel 302 and re-seals when the needle or
implement is removed. The plug 310 may be inserted into the
processing vessel 302 such that a seal is maintained between the
plug 310 and the processing vessel 302, such as by an interference
fit. Alternatively, the plug 310 can be formed in the closed end
304 of the processing vessel 302 using heated liquid rubber that
can be shaped while warm or hot and hardens as the rubber cools. An
adhesive may be used to attach a plug 310 to the inner wall of the
processing vessel can be a polymer-based adhesive, an epoxy, a
contact adhesive or any other suitable material for bonding or
creating a thermal bond. Alternatively, the plug 310 may be
injected into the processing vessel 302. Alternatively, the plug
310 may be thermally bonded to the processing vessel 302.
[0033] In the example of FIG. 3B, the cannula 214 has a tapered tip
that punctures the plug 310 and extends into an inner cavity of the
processing vessel 302 with the shaft of the cannula 214 not
extending into the inner cavity of the processing vessel 302. As
explained in greater detail below, the inner cavity of the
processing vessel 302 holds the target material. The cannula 214
may be covered by a resealable sleeve (not shown) to prevent the
target material from flowing out unless the processing vessel 302
is in the cavity 212 to a depth that allows the cannula 214 to just
penetrate the processing vessel 302. The resealable sleeve (not
shown) covers the cannula 214, is spring-resilient, can be
penetrated by the cannula 214, and is made of an elastomeric
material capable of withstanding repeated punctures while still
maintaining a seal.
[0034] As shown in FIGS. 3A-3B, the processing vessel 302 may be
loaded with a displacement fluid 312 prior to insertion into the
collector 200. The displacement fluid 312 displaces the target
material, such that when the collector 200 and processing vessel
302 are inserted into the primary vessel (not shown) including the
target material, and the collector, processing vessel, and primary
vessel undergo centrifugation, the displacement fluid 312 flows out
of the processing vessel 302 and into the primary vessel, and,
through displacement, such as through buoyant displacement (i.e.
lifting a material upwards), pushes the target material through the
cannula 214 and into the processing vessel 302.
[0035] The displacement fluid 312 has a greater density than the
density of the target material of the suspension (the density may
be greater than the density of a subset of suspension fractions or
all of the suspension fractions) and is inert with respect to the
suspension materials. The displacement fluid 312 may be miscible or
immiscible in the suspension fluid. Examples of suitable
displacement fluids include, but are not limited to, solution of
colloidal silica particles coated with polyvinylpyrrolidone (e.g.
Percoll), polysaccharide solution (e.g. Ficoll), iodixanol (e.g.
OptiPrep), an organic solvent, a liquid wax, an oil, a gas, and
combinations thereof; olive oil, mineral oil, silicone oil,
immersion oil, mineral oil, paraffin oil, silicon oil,
fluorosilicone, perfluorodecalin, perfluoroperhydrophenanthrene,
perfluorooctylbromide, and combinations thereof; organic solvents
such as 1,4-Dioxane, acetonitrile, ethyl acetate, tert-butanol,
cyclohexanone, methylene chloride, tert-Amyl alcohol, tert-Butyl
methyl ether, butyl acetate, hexanol, nitrobenzene, toluene,
octanol, octane, propylene carbonate, tetramethylene sulfones, and
ionic liquids; polymer-based solutions; surfactants;
perfluoroketones, such as perfluorocyclopentanone and
perfluorocyclohexanone, fluorinated ketones, hydrofluoroethers,
hydrofluorocarbons, perfluorocarbons, perfluoropolyethers, silicon
and silicon-based liquids, such as phenylmethyl siloxane; and
combinations thereof.
[0036] The processing vessel 302 may also include a processing
solution (not shown) to effect a transformation on the target
material when the target material enters the processing vessel 302.
The processing solution (not shown) may be a preservative, a cell
adhesion solution, a dye, or the like. Unlike the displacement
fluid 312, most, if not all, of the processing solution (not shown)
remains within the processing vessel 302 upon centrifugation,
thereby effecting the transformation on the target material in one
manner or another (i.e. preserving, increasing adhesion properties,
or the like). The processing solution (not shown) may be introduced
as a liquid or as a liquid contained in a casing. The casing may be
dissolvable in an aqueous solution but not in the displacement
fluid 312 (such as gel cap); or, the casing may be breakable, such
that the casing breaks when the processing vessel 302 is shaken in
a vortex mixer. Additionally, more than one processing solution may
be used.
[0037] The processing vessel 302 may include a flexible cap that
can be pushed to dispense a pre-determined volume therefrom and
onto a substrate, such as a slide or a well plate. The cap 308 may
be flexible or the cap 308 may be removed and the flexible cap
inserted into the open end 306. Alternatively, the processing
vessel 302 may be attached to (i.e. after accumulating the target
material) or may include a dispenser, which is capable of
dispensing a pre-determined volume of target material from the
processing vessel 302 onto another substrate, such as a microscope
slide. The dispenser may repeatedly puncture the re-sealable cap
308 or compress the material within the processing vessel 302 to
withdraw and dispense the pre-determined volume of target material
onto the substrate. Alternatively, the cap 308 may be removed and
the dispenser (not shown) may be inserted directly into the
processing vessel 302 to dispense the buffy coat-processing
solution mixture.
Collector-Canopy System
[0038] FIG. 4A shows an exploded view of the example collector 200
and canopy 402. FIG. 4B shows a cross-sectional view of the
processing vessel 402 inserted into the cavity 212 of the collector
200 taken along the line V-V shown in FIG. 4A. The collector 200
and canopy 402 form a collector-canopy system 400. The canopy 402
is similar to the processing vessel 302, except that the canopy has
a second open end 404. When the collector-canopy system 400 is
inserted into the primary vessel, some fluid within the primary
vessel, such as a portion of the suspension, a portion of a
suspension fraction, a portion of a clearing fluid, or the like,
may be discharged through the cannula 214. The canopy 402 inhibits
a portion of the fluid in the primary vessel that may be discharged
through the cannula 214 from escaping from the opening of the first
end 206 of the collector 200. The discharged fluid, having been
blocked by the canopy 402, flows out of the second open end 404,
and out of the window 218. Dashed lines 406 show fluid flow as the
fluid is discharged through the cannula 214 and retained by the
canopy 402.
[0039] Alternatively, when the collector 230 is used, the lid 236
of the collector 230 inhibits a portion of the fluid in the primary
vessel that may be discharged through the cannula 214 from escaping
from the opening of the first end 206 of the collector 200 in a
manner similar to that of the canopy 402.
Sealing Ring
[0040] FIG. 5A shows an isometric view of a sealing ring 500. FIG.
5B shows a top down view of the sealing ring 500. Dot-dashed line
502 represents the central or highest-symmetry axis of the sealing
ring 500. The sealing ring 500 includes an inner wall 504, an outer
wall 506, and a cavity 508. In FIG. 5B, R.sub.IW represents the
radial distance from the center of the sealing ring 500 to the
inner wall 504, and R.sub.OW represents the radial distance from
the center of the sealing ring 500 to the outer wall 506. The
sealing ring 500 is configured to fit around a primary vessel, such
as a tube. The cavity 508 is sized and shaped to receive the
primary vessel. The sealing ring 500 may be tightened, such that
the size of the cavity 508 and the radii of the inner and outer
walls 504 and 506 are reduced by circumferentially applying an
approximately uniform, radial force, such as the radial force
created by a clamp, around the outer wall 506 directed to the
central axis 502 of the sealing ring 500. When the sealing ring 500
is tightened around the primary vessel, the uniform force applied
to the sealing ring 500 is applied to the primary vessel, thereby
causing the primary vessel to constrict. When the radial force is
removed from the sealing ring 500, the sealing ring 500 remains
tightened and in tension around the primary vessel.
[0041] The sealing ring may be any shape, including, but not
limited to, circular, triangular, or polyhedral. FIG. 5C shows an
isometric view of a sealing ring 510. FIG. 5D shows a top down view
of the sealing ring 510. Sealing ring 510 is similar to sealing
ring 500, except sealing ring 510 is polyhedral. Dot-dashed line
512 represents the central or highest-symmetry axis of the sealing
ring 510. The sealing ring 510 includes an inner wall 514, an outer
wall 516, and a cavity 518. The sealing ring may be composed of a
metal, such as brass, a polymer, or combinations thereof.
[0042] Alternatively, as shown in FIG. 5E, a sealing ring 520 may
be composed of a piezoelectric material. FIG. 5F shows a top down
view of the sealing ring 520. Dot-dashed line 522 represents the
central or highest-symmetry axis of the sealing ring 520. The
sealing ring 520 may be connected to an electric potential source
528, such as a battery, via a first lead 524 and a second lead 526.
The electric potential source 528 creates a mechanical strain that
causes the sealing ring 520 to tighten (i.e. sealing ring 520 radii
decrease). The sealing ring 520 includes an inner wall 530, an
outer wall 532, and a cavity 534. In FIG. 5F, R.sub.IW represents
the radial distance from the center of the sealing ring 520 to the
inner wall 530, and R.sub.OW represents the radial distance from
the center of the sealing ring 520 to the outer wall 532.
Alternatively, the sealing ring 520 may be in a naturally tightened
stated. When applying the electric potential the sealing ring 520
expands. Alternatively, a portion of the sealing ring may be
composed of the piezoelectric material, such that the piezoelectric
portion acts as an actuator to cause the other portion of the
sealing ring to tighten and apply the substantially uniform
circumferential pressure on the primary vessel, thereby
constricting the primary vessel to form the seal.
[0043] FIG. 5G shows an isometric view of a sealing ring 540. The
sealing ring includes an adjustment mechanism 548 to adjust the
inner diameter R.sub.ID. The collapsible ring includes a first end
542 and a second end 546, the first and second ends 542 and 546
being joined by a band portion 544. The first and second ends 542
and 546 include complementary portions of the adjustment mechanism
548. The adjustment mechanism 548 includes, but is not limited to,
a ratchet, tongue and groove, detents, or the like.
[0044] The sealing ring may also include a thermal element, such as
a heated wire. The thermal element may soften the primary vessel
for constriction. Alternatively, the thermal element may melt the
primary vessel to provide a more adherent seal. Alternatively, the
thermal element may cause the sealing ring to compress, thereby
forming a seal between the primary vessel and float.
Sequential Density Fractionation Method
[0045] Sequential density fractionation is the division of a sample
into fractions or of a fraction of a sample into sub-fractions by a
step-wise or sequential process, such that each step or sequence
results in the collection or separation of a different fraction or
sub-fraction from the preceding and successive steps or sequences.
In other words, sequential density fractionation provides
individual sub-populations of a population or individual
sub-sub-populations of a sub-population of a population through a
series of steps. For example, Buffy coat is a fraction of a whole
blood sample. The Buffy coat fraction can be further broken down
into sub-fractions including, but not limited to, reticulocytes,
granulocytes, lymphocytes/monocytes, and platelets. These
sub-fractions may be obtained individually by performing sequential
density fractionation.
[0046] For the sake of convenience, the methods are described with
reference to an example suspension of anticoagulated whole blood.
But the methods described below are not intended to be so limited
in their scope of application. The methods, in practice, can be
used with any kind of suspension. For example, a sample suspension
can be urine, blood, bone marrow, cystic fluid, ascites fluid,
stool, semen, cerebrospinal fluid, nipple aspirate fluid, saliva,
amniotic fluid, vaginal secretions, mucus membrane secretions,
aqueous humor, vitreous humor, vomit, and any other physiological
fluid or semi-solid. It should also be understood that a target
material can be a fraction of a sample suspension, such as buffy
coat, a cell, such as ova, fetal material (such as trophoblasts,
nucleated red blood cells, fetal red blood cells, fetal white blood
cells, fetal DNA, fetal RNA, or the like), or a circulating tumor
cell ("CTC"), a circulating endothelial cell, an immune cell (i.e.
naive or memory B cells or naive or memory T cells), a vesicle, a
liposome, a protein, a nucleic acid, a biological molecule, a
naturally occurring or artificially prepared microscopic unit
having an enclosed membrane, parasites (e.g. spirochetes, such as
Borrelia burgdorferi which cause Lyme disease; malayria-inducing
agents), microorganisms, viruses, or inflammatory cells.
Alternatively, the sample may be a biological solid, such as
tissue, that has been broken down, such as by collagenase, prior to
or after being added to the primary vessel.
[0047] FIG. 6 shows a flow diagram for an example method for
retrieving a target material using sequential density
fractionation. In block 602, a suspension, such as anticoagulated
whole blood, is obtained. In block 604, the whole blood is added to
a primary vessel, such as a test tube. A float may also be added to
the primary vessel. For the sake of convenience, the methods are
described with reference to the float, but the methods described
below are not intended to be so limited in their application and
may be performed without the float.
[0048] FIG. 7A shows an isometric view of an example primary vessel
and float system 700. The system 700 includes a primary vessel 702
and a float 704 suspended within whole blood 706. In the example of
FIG. 7A, the primary vessel 702 has a circular cross-section, a
first open end 710, and a second closed end 708. The open end 710
is sized to receive a cap 712. The primary vessel may also have two
open ends that are sized to receive caps, such as the example tube
and separable float system 720 shown
[0049] Figure M. The system 720 is similar to the system 700 except
the primary vessel 702 is replaced by a primary vessel 722 that
includes two open ends 724 and 726 configured to receive the cap
712 and a cap 728, respectively. The primary vessels 702 and 722
have a generally cylindrical geometry, but may also have a tapered
geometry that widens, narrows, or a combination thereof toward the
open ends 710 and 724, respectively. Although the primary vessels
702 and 722 have a circular cross-section, in other embodiments,
the primary vessels 702 and 722 can have elliptical, square,
triangular, rectangular, octagonal, or any other suitable
cross-sectional shape that substantially extends the length of the
tube. The primary vessels 702 and 722 can be composed of a
transparent, semitransparent, opaque, or translucent material, such
as plastic or another suitable material. The primary vessels 702
and 722 each include a central axis 718 and 730, respectively. The
primary vessel 702 may also include a septum 714, as seen in
magnified view 716, at the closed end 708 to permit the removal of
a fluid, the suspension, or a suspension fraction, whether with a
syringe, a pump, by draining, or the like. The primary vessel 702
may have an inner wall and a first diameter.
[0050] The septum 714 may be composed of re-sealable rubber or
other suitable re-sealable material that can be repeatedly
punctured with a needle or other sharp implement to access the
contents of the primary vessel 702 interior and re-seals when the
needle or implement is removed. The septum 714 may be inserted into
the primary vessel 702 such that a seal is maintained between the
septum 714 and the primary vessel 702, such as by an interference
fit. Alternatively, the septum 714 can be formed in the openings
and/or the bottom interior of the tube using heated liquid rubber
that can be shaped while warm or hot and hardens as the rubber
cools. An adhesive may be used to attach the septum 714 to the wall
of the opening and tube interior and can be a polymer-based
adhesive, an epoxy, a contact adhesive or any other suitable
material for bonding rubber to plastic or creating a thermal bond.
Alternatively, the septum 714 may be thermally bonded to the
primary vessel 702.
[0051] The float 704 includes a main body, two teardrop-shaped end
caps, and support members radially spaced and axially oriented on
the main body. Alternatively, the float 704 may not include any
support members. Alternatively, the float 704 may include support
members which do not engage the inner wall of the primary vessel
702.
[0052] In alternative embodiments, the number of support members,
support member spacing, and support member thickness can each be
independently varied. The support members can also be broken or
segmented. The main body is sized to have an outer diameter that is
less than the inner diameter of the primary vessel 702, thereby
defining fluid retention channels between the outer surface of the
main body and the inner wall of the primary vessel 702. The
surfaces of the main body between the support members can be flat,
curved or have another suitable geometry. The support members and
the main body may be a singular structure or may be separate
structures.
[0053] Embodiments include other types of geometric shapes for
float end caps. The top end cap may be teardrop-shaped,
dome-shaped, cone-shaped, or any other appropriate shape. The
bottom end cap may be teardrop-shaped, dome-shaped, cone-shaped, or
any other appropriate shape. In other embodiments, the main body of
the float 704 can include a variety of different support structures
for separating samples, supporting the tube wall, or directing the
suspension fluid around the float during centrifugation.
Embodiments are not intended to be limited to these examples. The
main body may include a number of protrusions that provide support
for the tube. In alternative embodiments, the number and pattern of
protrusions can be varied. The main body may include a single
continuous helical structure or shoulder that spirals around the
main body creating a helical channel. In other embodiments, the
helical shoulder can be rounded or broken or segmented to allow
fluid to flow between adjacent turns of the helical shoulder. In
various embodiments, the helical shoulder spacing and rib thickness
can be independently varied. In another embodiment, the main body
may include a support member extending radially from and
circumferentially around the main body. In another embodiment, the
support members may be tapered.
[0054] The float 704 can be composed of a variety of different
materials including, but not limited to, metals; organic or
inorganic materials; ferrous plastics; sintered metal; machined
metal; plastic materials and combinations thereof. The primary
vessel 702 may have an inner wall and a first diameter. The float
704 can be captured within the primary vessel 702 by an
interference fit, such that under centrifugation, an inner wall of
the tube expands to permit axial movement of the float 704. When
centrifugation stops, the inner wall reduces back to the first
diameter to induce the interference fit. Alternatively, the inner
wall may not expand and the interference fit may not occur between
the float 704 and the primary vessel 702, such that the float moves
freely within the tube before, during, or after centrifugation. The
end caps of the float may be manufactured as a portion of the main
body, thereby being one singular structure, by machining, injection
molding, additive techniques, or the like; or, the end caps may be
connected to the main body by a press fit, an adhesive, a screw,
any other appropriate method by which to hold at least two pieces
together, or combinations thereof.
[0055] The cap 712 may be composed of a variety of different
materials including, but not limited to, organic or inorganic
materials; plastic materials; and combination thereof.
[0056] Returning to FIG. 6, in block 606, the primary vessel, the
float, and the whole blood undergo density-based separation, such
as by centrifugation, thereby permitting separation of the whole
blood into density-based fractions along an axial position in the
tube based on density. FIG. 8 shows an isometric view of the
primary vessel and float system 700 having undergone density-based
separation, such as by centrifugation. Suppose, for example, the
centrifuged whole blood includes three fractions. For convenience
sake, the three fractions include plasma, buffy coat, and red blood
cells. However, when another suspension undergoes centrifugation,
there may be more than, less than, or the same number of fractions,
each fraction having a different density. The suspension undergoes
axial separation into three fractions along the length the tube
based on density, with red blood cells 803 located on the bottom,
plasma 801 located on top, and buffy coat 802 located in between,
as shown in FIG. 8. The float 704 may have any appropriate density
to settle within one of the fractions. The density of the float 704
can be selected so that the float 704 expands the buffy coat 802
between the main body of the float and the inner wall of the
primary vessel. The buffy coat 802 can be trapped within an area
between the float 704 and the primary vessel 702.
[0057] At least one delineation fluid (not shown) may be used to
provide further separation between the target material and any
non-target material above and/or below the target material. The at
least one delineation fluid (not shown) may have a density greater
than or less than the target material. For example, when it is
desirous to further separate the buffy coat 802 and the red blood
cells 803, the delineation fluid may have a density greater than
the buffy coat 802 and less than the red blood cells 803. The at
least one delineation fluid (not shown) may be miscible or
immiscible with the suspension fluid and inert with respect to the
suspension materials. The at least one delineation fluid (not
shown) may also provide an area in which to seal the primary vessel
702, because there is greater delineation and separation between
the buffy coat 802 and the red blood cells 803. The at least one
delineation fluid (not shown) may be used whether or not a float is
used. Examples of suitable delineation fluids include, but are not
limited to, solution of colloidal silica particles coated with
polyvinylpyrrolidone (e.g. Percoll), polysaccharide solution (e.g.
Ficoll), iodixanol (e.g. OptiPrep), cesium chloride, sucrose,
sugar-based solutions, polymer-based solutions, surfactants, an
organic solvent, a liquid wax, an oil, a gas, and combinations
thereof; olive oil, mineral oil, silicone oil, immersion oil,
mineral oil, paraffin oil, silicon oil, fluorosilicone,
perfluorodecalin, perfluoroperhydrophenanthrene,
perfluorooctylbromide, and combinations thereof; organic solvents
such as 1,4-Dioxane, acetonitrile, ethyl acetate, tert-butanol,
cyclohexanone, methylene chloride, Cert-Amyl alcohol, tert-Butyl
methyl ether, butyl acetate, hexanol, nitrobenzene, toluene,
octanol, octane, propylene carbonate, tetramethylene sulfones, and
ionic liquids; polymer-based solutions; surfactants;
perfluoroketones, such as perfluorocyclopentanone and
perfluorocyclohexanone, fluorinated ketones, hydrofluoroethers,
hydrofluorocarbons, perfluorocarbons, perfluoropolyethers, silicon
and silicon-based liquids, such as phenylmethyl siloxane; and
combinations thereof.
[0058] FIG. 9 shows a seal being formed to prevent fluids from
moving up or down within the primary vessel. The seal also inhibits
float movement. The sealing ring 500 exerts circumferential or
radial forces on the primary vessel 702, thereby causing the
primary vessel 702 to collapse inwardly against the float 704.
Magnified view 902 shows the sealing ring 500 tightened around the
float and primary vessel system 700. The sealing ring 500, having
been placed at an interface of the huffy coat 802 and the red blood
cells 803, causes the primary vessel 702 to collapse inwardly until
a seal is formed between the primary vessel 702 and the float 704.
An outer wall of the sealing ring 500 may sit flush with an outer
wall of the primary vessel 702; the outer wall of the sealing ring
500 may extend past the outer wall of the primary vessel 702; or,
the outer wall of the primary vessel 702 may extend past the outer
wall of the sealing ring 500. The sealing ring 500 remains
tightened to maintain the seal, which prevents fluids from moving
past the seal in any direction. The sealing ring 500 may also
remain in tension. Alternatively, the sealing ring 500 may be
overtightened and then the force applied to the sealing ring 500 is
removed. The sealing ring 500 may expand slightly, though still
remains constricted.
[0059] To apply the sealing ring 500 and thereby form the seal, a
clamp may be used to circumferentially apply a force directed
toward the central axis of the primary vessel 702 to the sealing
ring 500 and the float and primary vessel system 700. The sealing
ring 500 is placed around the float and primary vessel system 700
after the float and primary vessel system 700 have undergone
density-based separation, such as by centrifugation. The sealing
ring 500 and float and primary vessel system 700 are then placed
into the clamp. The clamp may include a shelf to support the
sealing ring 500 against the primary vessel 702. Operation of the
clamp may be automated or may be performed manually. Alternatively,
the clamp may form a seal between the float 704 and primary vessel
702 without the inclusion of the sealing ring 500. Alternatively, a
seal may be formed between the float 704 and the primary vessel 702
such as by ultrasonic welding; or by applying heat or a temperature
gradient to deform and/or melt the primary vessel 702 to the float
704. For the sake of convenience, the methods are described with
reference to the seal between the float and the primary vessel, but
the methods described below are not intended to be so limited in
their application and may be performed without the seal.
[0060] When operation of the clamp is automated, a motor causes
translation of either a collet, including collet fingers, or a
pressure member to cause compression of the collet fingers. The
motor may be connected to the collet or the pressure member by a
shaft, such as a cam shaft, and one or more gears. A base engages
and holds the object. When the collet is driven by the motor, the
pressure member remains stationary. When the pressure member is
driven by the motor, the collet remains stationary. The clamp may
include a release, so as to cause the pressure member to slide off
of the collet fingers 904, thereby removing the clamping force.
[0061] Alternatively, the clamp may be, but is not limited to, a
collet clamp, an O-ring, a pipe clamp, a hose clamp, a spring
clamp, a strap clamp, or a tie, such as a zip tie. The clamp may be
used without a sealing ring to provide a seal between a float and a
tube.
[0062] The plasma 801 may be removed from the primary vessel 702,
as shown in FIG. 10A, such as by pipetting, suctioning, pouring, or
the like. Returning to FIG. 6, in block 608, a clearing fluid may
be added to the primary vessel along with a collector-canopy
system. FIGS. 10B-10C show a clearing fluid 1002 having a density
greater than at least the buffy coat 802 (i.e. may have a density
greater than the buffy coat but less than the red blood cells, or
may have a density greater than both the buffy coat and the red
blood cells, for example) being added to the primary vessel 702.
Alternatively, the plasma 801 may remain in the primary vessel 702.
When the plasma 801 remains in the primary vessel 702, the density
of the plasma 801 may be altered, such as by iodixanol or any
appropriate substance to change a fraction density, thereby acting
as the clearing fluid. Therefore, when the plasma 801 remains in
the primary vessel 702 and the density is altered, no clearing
fluid may be needed.
[0063] The collector-canopy system 400 is then added to the primary
vessel 702, as shown in FIG. 10D. The second end 208 of the
collector 200 forms a seal 1008 with the inner wall of the primary
vessel 702 to prevent fluid from flowing around the collector 200
before, during, and after centrifugation. The seal 1008 may be
formed between the second end 208 and an inner wall of the primary
vessel to maintain a fluid-tight sealing engagement before, during,
and after centrifugation and to inhibit any portion of the
suspension from being located or flowing between an inner wall of
the primary vessel and a main body 204 of the collector 200. The
seal may be formed by an interference fit, a grease (such as vacuum
grease), an adhesive, an epoxy, thermal bonding, ultrasonic
welding, clamping (such as with a ring or clamp), an insert that
fits between the second end 208 and the inner wall of the primary
vessel, or the like. A lock ring 1004 may be placed over the
shoulder 216 of the collector 200 and the open end 710 of the
primary vessel 702 to inhibit translation of the collector 200
relative to the primary vessel 702. When the collector-canopy
system 400 is inserted, a portion of the clearing fluid 1002 in the
primary vessel 702 may be discharged through the cannula 214 and
stopped by the canopy 402. The discharged fluid may flow out
through the window 218 and into the primary vessel 702, though
remaining above the seal between the second end 208 and the inner
wall of the primary vessel 702, as seen by the dashed lines 406 in
magnified view 1006 which is taken along the line VI-VI.
[0064] In block 610, sequential density fractionation is performed.
Block 610 is also a snapshot of the sequential density
fractionation steps. In block 612, an n.sup.th processing vessel
including an n.sup.th displacement fluid is inserted into the
collector, such that n.sup.th is greater than or equal to first
(i.e. second, third, fourth, and so on) as seen in FIG. 10E.
Magnified view 1010, which is a cross-section taken along the line
VII-VII, shows the displacement fluid 312 in the processing vessel
302 and the clearing fluid 1002 and the huffy coat 802 in the
primary vessel 702.
[0065] Returning to FIG. 6, in block 614, system is centrifuged to
collect a fraction or sub-fraction and the nth processing vessel is
removed. In block 616, the operator determines whether or not the
desired fraction or sub-fraction is obtained. When the desired
fraction or sub-fraction is obtained, the process may stop as shown
in block 618, though the process may continue until all fractions
or sub-fractions are obtained. When the desired fraction or
sub-fractions is not yet obtained, the process restarts at block
612. The processing vessels may also include a processing solution
to effect a change on the respective sub-fractions. Two or more
processing vessels and respective displacement fluids may be used
depending on the number of fractions or sub-fractions desired for
separation and collection. Each successive displacement fluid is
denser than the preceding displacement fluid. Similarly, each
successive fraction or sub-fraction is denser than the preceding
fraction or sub-fraction. Once collected, the consecutive
sub-fractions may be analyzed, such as for diagnostic, prognostic,
research purposes, to determine components characteristics (i.e. a
complete blood count), how those characteristics change over time,
or the like.
[0066] FIG. 10F shows the collector-processing vessel system 300
and the primary vessel 702 undergoing centrifugation. Magnified
view 1012, which is a cross-section view taken along the line
VIII-VIII, shows a snapshot of the exchange of fluids between the
primary vessel 702 and the processing vessel 302. As the clearing
fluid 1002, having a greater density than the buffy coat 802, moves
down in the primary vessel 702, the buffy coat 802 is cleared from
the float 704. As the displacement fluid 312, having a density
greater than a first subfraction 1014 of the buffy coat 802 but
less than the clearing fluid 1002 and the remainder of the buffy
coat 802, flows from the processing vessel 302 into the primary
vessel 702, the first subfraction 1014 moves upwards within the
primary vessel 702 through the funnel 222 and the cannula 214, and
into the processing vessel 302. As shown in FIG. 10G, the first
subfraction 1014 is in the processing vessel 302, while the
displacement fluid 312 and the clearing fluid 1002 are in the
primary vessel 702.
[0067] The processing vessel 302 including the first subfraction
1014 may then be removed from the collector 200 to undergo further
processing, analysis, storage, or the like. After removing the
processing vessel 302, a processing solution may be added, though
the processing solution may have already been in the processing
vessel prior to retrieval of the target material. The processing
vessel may be shaken, such as by a vortex mixer. The processing
solution (not shown), having been added before shaking either in
liquid form, in a dissolvable casing, or in a breakable casing, may
then mix with the buffy coat to effect a transformation and form a
buffy coat-processing solution mixture. The buffy coat-processing
solution mixture may then be dispensed onto a substrate, such as a
microscope slide.
[0068] Subsequent processing vessels and displacement fluids may be
used to collect additional subtractions of the buffy coat 802 until
all subtractions are collected or until the desired subfraction is
collected. Though sequential density fractionation is described as
being performed with a float and a sealing ring, sequential density
fractionation may be performed without a float, a sealing ring, or
both. The following is an example method for performing sequential
density fractionation: [0069] 1. Add blood and float to tube.
[0070] 2. Centrifuge to effect a density-based separation of the
blood (i.e. plasma, Buffy coat, and red blood cells). [0071] 3.
Apply sealing ring around the tube and float at a bottom end of the
float; clamp. [0072] 4. Remove plasma. [0073] 5. Add clearing fluid
which has a density greater than the density of the target
material. [0074] 6. Insert collector-processing vessel system, a
first processing vessel including a first displacement fluid having
a first density. [0075] 7. Re-centrifuge. [0076] 8. Remove the
first processing vessel which now includes a first sub-fraction of
the Buffy coat less dense than the first displacement fluid. [0077]
9. Insert a second processing vessel into the collector, the second
processing vessel including a second displacement fluid having a
second density which is greater than the first displacement fluid
and less than the clearing fluid. [0078] 10. Re-centrifuge. [0079]
11. Remove the second processing vessel which now includes a second
sub-fraction of the Buffy coat less dense than the second
displacement fluid and denser than both the first displacement
fluid and the first sub-fraction. [0080] 12. Repeat steps 9-11
using successively denser displacement fluids so as to collect
successively denser sub-fractions until all desired sub-fractions
are obtained.
[0081] The target material may be analyzed using any appropriate
analysis method or technique, though more specifically
extracellular and intracellular analysis including intracellular
protein labeling; chromogenic staining; molecular analysis; genomic
analysis or nucleic acid analysis, including, but not limited to,
genomic sequencing, DNA arrays, expression arrays, protein arrays,
and DNA hybridization arrays; in situ hybridization ("ISH"--a tool
for analyzing DNA and/or RNA, such as gene copy number changes);
polymerase chain reaction ("PCR"); reverse transcription PCR; or
branched DNA ("bDNA"--a tool for analyzing DNA and/or RNA, such as
mRNA expression levels) analysis. These techniques may require
fixation, permeabilization, and isolation of the target material
prior to analysis. Some of the intracellular proteins which may be
labeled include, but are not limited to, cytokeratin ("CK"), actin,
Arp2/3, coronin, dystrophin, FtsZ, myosin, spectrin, tubulin,
collagen, cathepsin D, ALDH, PBGD, Akt1, Akt2, c-myc, caspases,
survivin, p27.sup.kip, FOXC2, BRAF, Phospho-Akt1 and 2,
Phospho-Erk1/2, Erk1/2, P38 MAPK, Vimentin, ER, PgR, PI3K, pFAK,
KRAS, ALKH1, Twist1, Snail1, ZEB1, Fibronectin, Slug, Ki-67, M30,
MAGEA3, phosphorylated receptor kinases, modified histones,
chromatin-associated proteins, and MAGE. To fix, permeabilize, or
label, fixing agents (such as formaldehyde, formalin, methanol,
acetone, paraformaldehyde, or glutaraldehyde), detergents (such as
saponin, polyoxyethylene, digitonin, octyl .beta.-glucoside, octyl
.beta.-thioglucoside, 1-S-octyl-.beta.-D-thioglucopyranoside,
polysorbate-20, CHAPS, CHAPSO,
(1,1,3,3-Tetramethylbutyl)phenyl-polyethylene glycol or octylphenol
ethylene oxide), or labeling agents (such as fluorescently-labeled
antibodies, enzyme-conjugated antibodies, Pap stain, Giemsa stain,
or hematoxylin and eosin stain) may be used.
[0082] After collection, the target material may also be imaged. To
be imaged, a solution containing a fluorescent probe may be used to
label the target material, thereby providing a fluorescent signal
for identification and characterization, such as through imaging.
The solution containing the fluorescent probe may be added to the
suspension before the suspension is added to the vessel, after the
suspension is added to the vessel but before centrifugation, or
after the suspension has undergone centrifugation. The fluorescent
probe includes a fluorescent molecule bound to a ligand. The target
material may have a number of different types of surface markers.
Each type of surface marker is a molecule, such an antigen, capable
of attaching a particular ligand, such as an antibody. As a result,
ligands can be used to classify the target material and determine
the specific type of target materials present in the suspension by
conjugating ligands that attach to particular surface markers with
a particular fluorescent molecule. Examples of suitable fluorescent
molecules include, but are not limited to, quantum dots;
commercially available dyes, such as fluorescein, Hoechst, FITC
("fluorescein isothiocyanate"), R-phycoerythrin ("PE"), Texas Red,
allophycocyanin, Cy5, Cy7, cascade blue, DAPI
("4',6-diamidino-2-phenylindole") and TRITC ("tetramethylrhodamine
isothiocyanate"); combinations of dyes, such as CY5PE, CY7APC, and
CY7PE; and synthesized molecules, such as self-assembling nucleic
acid structures. Many solutions may be used, such that each
solution includes a different type of fluorescent molecule bound to
a different ligand.
[0083] When the target material is collected and is mixed within
non-target material, the density of the target or non-target
material may be increased (such as by attaching a weight to the
target or non-target material or by having the target or non-target
material absorb or ingest the weight) or may be decreased (such as
by attaching a buoy to the target or non-target material or by
having the target or non-target material absorb or ingest the
buoy). The weight or the buoy may be bound to a ligand. The target
material may have a number of different types of surface markers.
Each type of surface marker is a molecule, such as an antigen,
capable of attaching a particular ligand, such as an antibody. As a
result, ligands can be selected to attached specifically to the
target or non-target material. Examples of suitable weights and/or
buoys include, but are not limited to beads composed of metal,
glass, ceramic, plastic, or combinations thereof. After the
collection step and the density-altering step, a second round of
sequential density fraction may be performed, thereby obtaining a
purer target material or individual components of the target
material.
[0084] The foregoing description, for purposes of explanation, used
specific nomenclature to provide a thorough understanding of the
disclosure. However, it will be apparent to one skilled in the art
that the specific details are not required in order to practice the
systems and methods described herein. The foregoing descriptions of
specific embodiments are presented by way of examples for purposes
of illustration and description. They are not intended to be
exhaustive of or to limit this disclosure to the precise forms
described. Many modifications and variations are possible in view
of the above teachings. The embodiments are shown and described in
order to best explain the principles of this disclosure and
practical applications, to thereby enable others skilled in the art
to best utilize this disclosure and various embodiments with
various modifications as are suited to the particular use
contemplated. It is intended that the scope of this disclosure be
defined by the following claims and their equivalents:
* * * * *